Merus N.v. buy BiotechBee
Start price
24.06.23
/
70%
€23.20
Target price
30.04.26
€40.00
Performance (%)
76.72%
End price
14.12.24
€41.00
Summary
This prediction ended on 14.12.24 with a price of €41.00. With a performance of 76.72% the BUY prediction by BiotechBee was a big success. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merus N.v. | - | - | - |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% |
According to BiotechBee what are the pros and cons of Merus N.v. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year